An exception was solitary fibrous tumor (SFT), which is driven by the NAB2-STAT6 fusion oncogene, and has oncogenic TP53 alteration in 28% of cases (Fig. 4A)18. This evidence concerns the gene NAB2 and solitary fibrous tumor.